Recall Register

Food, drugs, devices › Diagnostica Stago, Inc.

Device recall: STA UNICALIBRATOR (ref. 00675)

FDA enforcement event 84402 · Class II · initiated 18 Nov 2019 · status Terminated · terminated 12 Jan 2023

DeviceVoluntary: Firm initiated2 product recordsParsippany, NJ

FDA enforcement event 84402 is a device recall by Diagnostica Stago, Inc. of Parsippany, NJ, initiated 18 Nov 2019 and classified Class II, with 2 product records.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 968 device enforcement events initiated in 2019 carry the same class.

Status: Terminated, terminated 12 Jan 2023. Initiation: voluntary: firm initiated. Diagnostica Stago, Inc. has 16 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Diagnostica Stago, Inc., Parsippany, NJ.

Reason for recall

"A positive bias was confirmed to exists on the STA - Unicalibrator levels with STA - Deficient IX and STA - Deficient VIII when compared to the International Standard (IS) for factor VIII or IX. This bias is also observed on several External Quality Assessment (EQA) results."

Distribution

"US: MA ME VT CT NJ NY PA DC MD VA NC SC GA FL AL TN MS KY OH IN MI IA WI MN SD ND MT IL MO KS LA AR OK TX CO AZ NV CA HI OR WA AK"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0737-2020STA UNICALIBRATOR (ref. 00675)5,498Class IITerminated1 Jan 2020
Z-0738-2020STA SYSTEM CONROL N + P (ref. 00678)5,437Class IITerminated1 Jan 2020

Context

88%of 2019 device events are Class II968 events that year
2product records in this eventfirm median: 1
16events on this register for the firm

Other enforcement events for Diagnostica Stago, Inc.

InitiatedProduct (first record)TypeClassRecords
29 Jul 2026STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiDeviceClass II1
5 Feb 2026Brand Name: STA Liatest D-Di Product Name: STA Liatest D-Di Model/Catalog Number: REF 00515 Product Description: in vitrDeviceClass II1
4 Feb 2026Brand Name: STA Liatest Free Protein S Product Name: STA Liatest Free Protein S Model/Catalog Number (REF): 00516 ProducDeviceClass II1
15 Dec 2025Asserachrom HPIA. Model/Catalog Number: 00615. The Asserachrom HPIA kit is intended for the qualitative detection in plaDeviceClass II1
12 Sep 2025Product: STA Liatest D-Di; REF: 00515;DeviceClass II1
21 Jul 2025STA Satellite. Product Code: All references. All software versions. The STA Satellite is a fully automated benchtop analDeviceClass II4
21 May 2025STA - Owren Koller. Model/Catalog Number: 00360 STA - Owren-Koller is a buffer solution intended for use as a diluent foDeviceClass II1
22 Mar 2023STA R Max fully automatic clinical instrument designed to perform tests on human plasmas, Reference Numbers 59013 and 59DeviceClass II3
4 Mar 2020STA - Deficient VIII, Product Code: 00725. STA - Deficient VIII is an immuno-depleted human plasma intended for use in tDeviceClass II1
14 Nov 2018Staclot¿ LA (REF 00600) The Staclot¿ LA and Staclot¿ LA 20 test kits are reagent systems designed for the qualitative deDeviceClass II2

All 16 events for Diagnostica Stago, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "A positive bias was confirmed to exists on the STA - Unicalibrator levels with STA - Deficient IX and STA - Deficient VIII when compared to the International Standard (IS) for factor VIII or IX. This bias is also observed on several External Quality Assessment (EQA) results."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "US: MA ME VT CT NJ NY PA DC MD VA NC SC GA FL AL TN MS KY OH IN MI IA WI MN SD ND MT IL MO KS LA AR OK TX CO AZ NV CA HI OR WA AK"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 12 Jan 2023. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.